Notifications
Back
Notification settings
Back
More
Post notifications
Post reactions
Be notified when someone leaves a comment or a reply to your post or comment.
Updates and news
Stay ahead of important updates and news from the site.
  • Alarm
    Profile image
  • My account Sign out
  • About us
    • Mission
    • Leaders
    • Contact
  • Platform Technology
    • Exosome
    • Maxisome
    • InProDel
    • Fusosome
  • Pipeline
    • Pipeline
    • SBI-102
  • Science
    • Manufacturing
    • SAB
    • Publication
    • Patent
  • CSO
    • What is CSO?
    • Why Choose Our CSO?
    • Inquiry
  • News
    • Notice
    • Press Release
  • English
  • 한국어
SHIFTBIO INC.
  • About us
  • Platform Technology
  • Pipeline
  • Science
  • CSO
  • News
Site logo Five-set® Five-set®
  • About us
    • Mission
    • Leaders
    • Contact
  • Platform Technology
    • Exosome
    • Maxisome
    • InProDel
    • Fusosome
  • Pipeline
    • Pipeline
    • SBI-102
  • Science
    • Manufacturing
    • SAB
    • Publication
    • Patent
  • CSO
    • What is CSO?
    • Why Choose Our CSO?
    • Inquiry
  • News
    • Notice
    • Press Release
Site logo Five-set® Five-set®
  • About us
    • Mission
    • Leaders
    • Contact
  • Platform Technology
    • Exosome
    • Maxisome
    • InProDel
    • Fusosome
  • Pipeline
    • Pipeline
    • SBI-102
  • Science
    • Manufacturing
    • SAB
    • Publication
    • Patent
  • CSO
    • What is CSO?
    • Why Choose Our CSO?
    • Inquiry
  • News
    • Notice
    • Press Release
MENU
About us
  • Mission
  • Leaders
  • Contact
Platform Technology
  • Exosome
  • Maxisome
  • InProDel
  • Fusosome
Pipeline
  • Pipeline
  • SBI-102
Science
  • Manufacturing
  • SAB
  • Publication
  • Patent
CSO
  • What is CSO?
  • Why Choose Our CSO?
  • Inquiry
News
  • Notice
  • Press Release
MENU
Site logo SHIFTBIO INC. SHIFTBIO INC.
  • About us
    • Mission
    • Leaders
    • Contact
  • Platform Technology
    • Exosome
    • Maxisome
    • InProDel
    • Fusosome
  • Pipeline
    • Pipeline
    • SBI-102
  • Science
    • Manufacturing
    • SAB
    • Publication
    • Patent
  • CSO
    • What is CSO?
    • Why Choose Our CSO?
    • Inquiry
  • News
    • Notice
    • Press Release

Press Release

  • Notice
  • Press Release
  • Notice
  • Press Release
Updates and news NEWS '2023 Hongneung Innovative Bio Forum'
0
0
31 Jan 2023 Views 46
Updates and news NEWS Happy New Year from SHIFTBIO
0
0
29 Dec 2022 Views 100
Updates and news NEWS "The communication tools between cells can be used as therapeutics."
0
0
27 Dec 2022 Views 103
Updates and news NEWS Congratulations on the second foundation anniversary of SHIFTBIO INC.
0
0
11 Nov 2022 Views 139
Updates and news NEWS Dr. In-San Kim, a co-founder of SHIFTBIO INC., has been appointed as a fellow researcher at the Korea Institute of Science and Technology (KIST)
0
0
4 Nov 2022 Views 155
Updates and news NEWS "Why to use EVs as the CD47 blockade?"
0
0
27 Oct 2022 Views 111
Updates and news NEWS SHIFTBIO INC announced the detailed realization plan upon The SBI-102 and the Intrinsic Nanovesicle-based platform technology
0
0
20 Oct 2022 Views 221
Updates and news NEWS SHIFTBIO INC and RoosterBio had a valuable discussion on the large-scale production process development of SHIFTBIO INC’s main pipeline, SBI-102, along with innovative business models
0
0
11 Oct 2022 Views 179
Updates and news NEWS Dr. Gi-Hoon Nam, Co-Founder of SHIFTBIO INC, has joined as a panelist at the 23rd World Knowledge Forum
0
0
26 Sep 2022 Views 181
Updates and news NEWS “SHIFTBIO, a company that puts the armor on the avatar of cells”
0
0
19 Aug 2022 Views 334
Updates and news NEWS SHIFTBIO INC. attended the GLOBAL INVESTMENT SUMMIT 2022
0
0
11 Jul 2022 Views 332
Updates and news NEWS Korea’s leading media group, JoongAng News interviewed SHIFTBIO
0
0
6 Jul 2022 Views 297
Updates and news NEWS Thomas M. Roberts and Kenneth W. Witwer became the first two official ShiftBio Scientific Advisory Board members!
0
0
20 Jun 2022 Views 467
Updates and news ShiftBio Co., Ltd. Selected as 2022 'First Penguin' by KODIT
0
0
3 Jun 2022 Views 320
Updates and news NEWS ShiftBio Partners with RoosterBio Inc. to Develop SBI-102 for Rare Diseases and Cancer
0
0
27 Apr 2022 Views 475
Updates and news ShiftBio presented at the 2022 Korea Conference in Los Angeles, USA!
0
0
30 Mar 2022 Views 387
Updates and news NEWS In-San Kim, MD, Ph.D. featured on the International Society for Extracellular Vesicles (ISEV) eNEWs
0
0
16 Mar 2022 Views 387
Updates and news ShiftBio sponsored and hosted the EVs and EVs-based Therapeutics Online Conference, Seoul!
0
0
7 Mar 2022 Views 380
Updates and news Co-founder of ShiftBio, Professor In-san Kim received ''The 1st Lim Sungki Researcher Award 2022'' !
0
0
28 Dec 2021 Views 464
Updates and news ShiftBio took 1st place in the Startup Section of Gangso Special Zone Innovative Growth IR Enterprise Contest!
0
0
26 Nov 2021 Views 922
Updates and news ShiftBio received the Best Excellence Award at the Bio IR Day to enjoy the MetaBus competition!
0
0
29 Oct 2021 Views 336
Updates and news ShiftBio is happy to announce to become the winner of the GRaND-K competition!
0
0
25 Oct 2021 Views 502
New post



#102, #103, 1st floor, 76, Hwarang-ro, Seongbuk-gu,  Seoul, Republic of Korea 

contact@shiftbio.net 

tel : 02-942-1109 


Copyright ⓒ 2023 SHIFTBIO INC. All rights reserved.